D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$820M |
| 2 |
Visa
V
|
+$667M |
| 3 |
HES
Hess
HES
|
+$515M |
| 4 |
Mastercard
MA
|
+$425M |
| 5 |
Oracle
ORCL
|
+$382M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Advanced Micro Devices
AMD
|
+$949M |
| 3 |
Citigroup
C
|
+$419M |
| 4 |
ExxonMobil
XOM
|
+$391M |
| 5 |
Booking.com
BKNG
|
+$349M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 40.59% |
| 2 | Technology | 18.36% |
| 3 | Consumer Discretionary | 9.46% |
| 4 | Financials | 6.95% |
| 5 | Healthcare | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TIGR
2151
UP Fintech Holding
TIGR
$851M
| $3.07M | ﹤0.01% |
893,045
-239,771
| -21% | -$950K |
|
2152
Invesco S&P 500 High Beta ETF
SPHB
$904M
| $3.07M | ﹤0.01% |
34,939
+30,039
| +613% | +$2.49M |
|
2153
Landstar System
LSTR
$5.78B
| $3.06M | ﹤0.01% |
15,892
-21,326
| -57% | -$4.05M |
|
2154
First Majestic Silver
AG
$9.78B
| $3.06M | ﹤0.01% |
520,792
-258,845
| -33% | -$1.3M |
|
2155
Jacobs Solutions
J
$16.8B
| $3.06M | ﹤0.01% |
24,065
+12,062
| +100% | +$1.41M |
|
2156
Employers Holdings
EIG
$880M
| $3.05M | ﹤0.01% |
67,280
-28,513
| -30% | -$1.22M |
|
2157
CALL
Polaris
PII
$3.08B
| $3.05M | ﹤0.01% |
30,500
-7,000
| -19% | -$643K |
|
2158
CALL
AMC Entertainment Holdings
AMC
$2.41B
| $3.05M | ﹤0.01% |
820,800
+720,800
| +721% | +$3.21M |
|
2159
Winmark
WINA
$1.03B
| $3.05M | ﹤0.01% |
8,440
+3,890
| +85% | +$1.43M |
|
2160
PUT
Peloton Interactive
PTON
$2.18B
| $3.05M | ﹤0.01% |
712,000
-270,000
| -27% | -$1.33M |
|
|
TRUE
2161
DELISTED
TrueCar
TRUE
| $3.05M | ﹤0.01% |
899,120
-93,340
| -9% | -$324K |
|
2162
CALL
Alaska Air
ALK
$4.52B
| $3.04M | ﹤0.01% |
70,800
| – | – |
|
2163
CALL
Caleres
CAL
$405M
| $3.04M | ﹤0.01% |
74,100
| – | – |
|
2164
Pacific Biosciences
PACB
$426M
| $3.03M | ﹤0.01% |
809,260
+798,405
| +7,355% | +$4.67M |
|
2165
iShares S&P Small-Cap 600 Value ETF
IJS
$7.92B
| $3.03M | ﹤0.01% |
+29,518
| New | +$2.93M |
|
2166
Cogent Biosciences
COGT
$5.47B
| $3.03M | ﹤0.01% |
451,232
+392,431
| +667% | +$2.43M |
|
2167
Haemonetics
HAE
$4.93B
| $3.02M | ﹤0.01% |
35,415
+7,160
| +25% | +$562K |
|
|
THS
2168
DELISTED
Treehouse Foods
THS
| $3.02M | ﹤0.01% |
77,577
+21,467
| +38% | +$850K |
|
2169
CALL
Federal Agricultural Mortgage
AGM
$2.4B
| $3.01M | ﹤0.01% |
15,300
-9,300
| -38% | -$1.73M |
|
2170
CALL
DexCom
DXCM
$33.7B
| $3.01M | ﹤0.01% |
21,700
-12,400
| -36% | -$1.56M |
|
2171
PUT
Bath & Body Works
BBWI
$3.51B
| $3M | ﹤0.01% |
60,000
| – | – |
|
2172
CALL
Lucid Motors
LCID
$1.61B
| $3M | ﹤0.01% |
105,140
+61,530
| +141% | +$1.96M |
|
2173
Arbor Realty Trust
ABR
$798M
| $2.99M | ﹤0.01% |
225,592
-263,515
| -54% | -$3.53M |
|
|
RRAC
2174
DELISTED
Rigel Resource Acquisition Corp.
RRAC
| $2.99M | ﹤0.01% |
267,479
| – | – |
|
|
SAGE
2175
DELISTED
Sage Therapeutics
SAGE
| $2.99M | ﹤0.01% |
159,338
-95,329
| -37% | -$2.2M |
|
Similar funds
D.E. Shaw & Co's Q1 2024 Portfolio in Review
As of Q1 2024, D.E. Shaw & Co held 4,923 positions worth $117B, up 2.1% from $114B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
D.E. Shaw & Co's Q1 2024 filing shows 655 new, 1,367 increased, 1,722 reduced and 634 closed positions. Its largest new stake was Arm: 2,379,839 shares worth $297M. The largest sale was NVIDIA, an estimated $1.03B.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 46% a quarter earlier, followed by Technology and Consumer Discretionary.
- D.E. Shaw & Co's largest Q1 2024 buy was Arm: 2,379,839 shares worth $297M.
- D.E. Shaw & Co added most to Apple in Q1 2024, an estimated $820M increase.
- D.E. Shaw & Co's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.03B.
- D.E. Shaw & Co fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2024, selling an estimated $307M.
- D.E. Shaw & Co's ten largest holdings make up 13% of its $117B portfolio in Q1 2024.
- D.E. Shaw & Co opened 655 new positions and closed 634 in Q1 2024.
- D.E. Shaw & Co's portfolio value rose 2.1% quarter-over-quarter to $117B.
Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.